Skip to main content
Clinical Trials/NL-OMON43723
NL-OMON43723
Completed
Not Applicable

Proteomics analysis of cerebrospinal fluid to investigate brain involvement in pre-eclampsia - LEPRA II (liquor cerebrospinalis and pre-eclampsia)

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
neurologische aandoeningen tijdens de zwangerschap
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Non pregnant women of 18 year and older

Exclusion Criteria

  • Pregnant during inclusion
  • Pre\-eclampsia in history
  • Auto\-immune disorders
  • Oral corticosteroid use
  • Hemoglobinopathy or clotting disorder
  • Chronic hypertension or proteinuria
  • Kidney disorders
  • Neurologic disorder

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Proteomics analysis of cerebrospinal fluid for screening of POCD-associated moleculesThoracic aortic aneurysm
JPRN-UMIN000035805Mie University20
Recruiting
Not Applicable
Proteomics of cerebrospinal fluid after remote ischemic preconditioninganeurysm of the thoracic aorta
JPRN-UMIN000034214Mie university hospital30
Completed
Not Applicable
Plasma and cerebrospinal fluid concentrations treated with daily dose and high dose weekly erlotinib in non-small cell lung cancer patients with central nervous system metastasescentral nervous system metastases of non-small cell lung cancer with active EGFR mutations treated with daily dosing erlotinib
JPRN-UMIN000004703Osaka City University10
Completed
Not Applicable
An investigation on spinal fluid in patients with sciatica-type or nerve-type pain of the lower limbeuropathic lower limb painNervous System Diseases
ISRCTN34007592Trinity Translational Medicine Institute12
Active, not recruiting
Not Applicable
Cerebrospinal fluid (CSF) and plasma pharmocokinetics of liposomal cytarabine (DepoCyte®) after intrathecal administration in children with malignant brain tumors and leptomeningeal disseminatioTo measure concentrations of liposomal cytarabine in CSF and plasma over time after intrathecal administration of liposomal cytarabine in children of different age groups with a malignant brain tumor and leptomenigeal dissemination. Measurements of concentrations of cytarabine after intrathecal administration of liposomal cytarabine will help to ensure proper dosage of liposomal cytarabine in small children, avoiding neurotoxic events and subtherapeutic drug levels.
EUCTR2006-004982-32-ATMedical University of Vienna, Department of Pedatrics